Search

everythinglearnresearchcommunity

for

Search:↓

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

HNG may help prevent the negative effects of chemotherapy on sperm production and white blood cell counts.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.